Transcript Adamed Spain – “a dream come true”

ADAMED Laboratorios SLU
* Dedicated in body and mind
“Instead of a passive waiting for what future
will bring us, we belive in a possibility of
creating it. From the very beggining…
This philosophy has been inspiring us till now.
We hope it will be also yours from tomorrow.”
Adamed Spain – “a dream come true”
OBJECTIVES:
ADAMED Laboratorios S.L.U. (Spain) is going to be a
dynamic and innovative pharmaceutical company focus on
CNS specialists an CNS pathologies in order to create addvalue services and high quality products that represents a
benefit for population.
the words (october 2008)
Adamed Spain
Characteristics:
Young company (average experience: 12 years in Spanish Market)
R&D Support of Adamed Poland
Innovative beyond products…specialist and patients contacts
Specialized in SNC specialists (complicate Area)
Gives high quality solutions
Dynamic and Flexible
Focused but with expansion expectations
Adamed Spain – “a dream come true”
FACTS:
Specialized in Specialist: Focus on CNS specialists (psychiatrist
and neurologist) focus on:
–
–
–
–
Schizophrenia Units
Bipolar Disease Units
Addictions Units
Parkinson Units
Our identity: quality and add-value services
–
–
Products manufactured in Europe
Closing work with Scientific societies, be a referent on CNS market
Adamed Products
PRODUCT
MOLECULE
LAUNCH DATE
Topiramate
(Antiepileptic drug)
April 2009
Quetiapine
(Antipsychotic drug)
April 2009
Lamotrigine
(Antiepileptic- Mood Stabilaser)
June 2009
Venlafaxine
(Dual Antidepressant)
May 2009
Pramipexol e
(Antiparkinsonian drug)
Sept. 2010
Clozapine
(Antipsychotic drug)
March 2011
Olanzapine
(Antipsychotic drug)
25th of April 2011
Adamed Evolution since launch
151%
142%
Adamed Spain – “a dream come true”
FACTS:
Focus on CNS Specialist with a high positioning with the KOL of
both societies.
Recognised high-cooperation with Health Authorities pharma
company
Developing projects closed to medical societies:
–
–
–
–
Suicide Recommendations – SEP. SEPB- FEPSM
Fornes Project
Book for BD patients and family
Best in Class Awards for Neuro Specialist
Awards received:
–
–
Launching Acomicil: Diario Médico
Book for BD patients and family
Projects developed with CNS specialist
“Recommendations for preventing
and managing Suicidal
behaviors”
Academia de Semiología
Neuro Best in Class Awards
ACO-TEXT Trial: Evaluating
adherence to treatment sending
daily SMS to patients with
addictions
Projects developed with CNS specialist
Adamed launching
Strategic Plan
Objectives:
Consolidate Adamed as a reference company for CNS
Be a reference for the CNS specialists
Support for patients and their families with information programs
Simplicity and dynamism as a basis for the company strategy:
– Working team
– Pharma business, market and customer Knowledge
– Value of well-done work
Adamed Spain
belongs to Adamed Group
POLAND
1986
SPAIN
(september 2008)
Some data…
1.500 people working in Adamed Poland
API, FP facilities (incl. Polfa and Agropharm adcquisitions)
25 patents
475 salesforce / 100 people working in R&D
150 M€ Polish market turnover after mergers / 20 M€ export sales
Introduced in many areas: cardio, CNS, gastro, respi, OTC…
New chemical entities: oncology, diabetes, CNS
Philosophy: “From generic to innovative pharma”
History of innovation in Adamed
PRIORITY AREAS OF OUR R &D:
Metabolic
Diseases
Research of
Innovative drugs
Cancer
Diseases
CNS
Diseases
Metabolic
Platform
Oncology
Platform
Neuropsychiatry
Platform